PMID- 16887934 OWN - NLM STAT- MEDLINE DCOM- 20061204 LR - 20220409 IS - 0026-895X (Print) IS - 0026-895X (Linking) VI - 70 IP - 5 DP - 2006 Nov TI - Hypoxia-inducible factor-1 (HIF-1). PG - 1469-80 AB - Adaptation to low oxygen tension (hypoxia) in cells and tissues leads to the transcriptional induction of a series of genes that participate in angiogenesis, iron metabolism, glucose metabolism, and cell proliferation/survival. The primary factor mediating this response is the hypoxia-inducible factor-1 (HIF-1), an oxygen-sensitive transcriptional activator. HIF-1 consists of a constitutively expressed subunit HIF-1beta and an oxygen-regulated subunit HIF-1alpha (or its paralogs HIF-2alpha and HIF-3alpha). The stability and activity of the alpha subunit of HIF are regulated by its post-translational modifications such as hydroxylation, ubiquitination, acetylation, and phosphorylation. In normoxia, hydroxylation of two proline residues and acetylation of a lysine residue at the oxygen-dependent degradation domain (ODDD) of HIF-1alpha trigger its association with pVHL E3 ligase complex, leading to HIF-1alpha degradation via ubiquitin-proteasome pathway. In hypoxia, the HIF-1alpha subunit becomes stable and interacts with coactivators such as cAMP response element-binding protein binding protein/p300 and regulates the expression of target genes. Overexpression of HIF-1 has been found in various cancers, and targeting HIF-1 could represent a novel approach to cancer therapy. FAU - Ke, Qingdong AU - Ke Q AD - Nelson Institute of Environmental Medicine, New York University School of Medicine, 57 Old Forge Road, Tuxedo, NY 10987, USA. FAU - Costa, Max AU - Costa M LA - eng PT - Journal Article PT - Review DEP - 20060803 PL - United States TA - Mol Pharmacol JT - Molecular pharmacology JID - 0035623 RN - 0 (Hypoxia-Inducible Factor 1) SB - IM MH - Animals MH - Gene Expression Regulation MH - Humans MH - Hypoxia-Inducible Factor 1/chemistry/genetics/*metabolism RF - 183 EDAT- 2006/08/05 09:00 MHDA- 2006/12/09 09:00 CRDT- 2006/08/05 09:00 PHST- 2006/08/05 09:00 [pubmed] PHST- 2006/12/09 09:00 [medline] PHST- 2006/08/05 09:00 [entrez] AID - mol.106.027029 [pii] AID - 10.1124/mol.106.027029 [doi] PST - ppublish SO - Mol Pharmacol. 2006 Nov;70(5):1469-80. doi: 10.1124/mol.106.027029. Epub 2006 Aug 3.